STC1 and ovarian serous carcinoma: In contrast to our findings, high expression of STC-1 has been shown to correlate with an advanced tumor grade in glioma and ovarian serous carcinomas, suggesting pleiotropic effects of STC-1 that depend on the type of cancer (47, 48).